Empress Therapeutics is to generate transformative drug candidates that get to the clinic faster and cheaper.
Empress Therapeutics has raised $50.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2023.
Empress Therapeutics's investors include Flagship Pioneering.
Empress Therapeutics is headquartered in Cambridge, United States.
Empress Therapeutics is to generate transformative drug candidates that get to the clinic faster and cheaper.
Empress Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Empress Therapeutics — Funding & Investors." VCBacked, June 21, 2023, https://www.vcbacked.co/company/empress-therapeutics. Accessed September 30, 2026.
VCBacked. (2023). Empress Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/empress-therapeutics
{{cite web |title=Empress Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/empress-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated